In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In ...

Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

"The agreement will also support the expansion of clinical studies for up to five additional subtypes of pandemic influenza." Under the Biden administration, HHS also pledged more than $300 ...

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...

Moderna is set to receive $590m in funding from the US Department of Health and Human Services (HHS) to expedite the development of mRNA-based pandemic influenza vaccines. The initiative is part ...

The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu ... with pandemic potential. The U.S. Department of Health and Human Services’ (HHS ...

But that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even probable. The Department of Health and Human Services (HHS), of which the CDC is part, believes the current bird ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...